IMU 0.00% 1.7¢ imugene limited

I sold my holding last year, and just bought back in...

  1. 7,694 Posts.
    lightbulb Created with Sketch. 92
    I sold my holding last year, and just bought back in today!
    Waiting for my re-entry for sometimes, and I think 1.4c is a reasonable bet on this recent trial results:

    The Phase 1b HER-Vaxx study which completed enrolment in 2018 met all its primary endpoints. The study is ongoing with patients continuing to receive HER-Vaxx every 3 months to maintain high levels of cancer targeting antibodies. A Phase 2 study was initiated in March 2019 dosing patients at the highest Phase 1b dose.The presentation details the continued progress being made by patients who received the highest dose of HER-Vaxx. By day 182 of the trial, their tumours have either shrunk further or stabilized. In one patient, their tumour has shrunk more than 70% since joining the trial. All patients on the highest dose have already received their day 266 doses and these results will be presented in an oral presentation at ESMO GI in Barcelona on 3-6 July 2019.
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap ! $61.36M
Open High Low Value Volume
1.7¢ 1.8¢ 1.7¢ $262.3K 15.31M

Buyers (Bids)

No. Vol. Price($)
5 1258706 1.7¢

Sellers (Offers)

Price($) Vol. No.
1.8¢ 4538483 10
View Market Depth
Last update - 16.10pm 19/07/2019 (20 minute delay) ?
0.000 ( 5.88 %)
Open High Low Volume
1.7¢ 1.8¢ 1.7¢ 706313
Last updated 15.47pm 19/07/2019 (live) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.